Bayer proposes $7.2 billion settlement to resolve weedkiller cases
Summary
Bayer’s Monsanto unit has proposed a $7.25 billion settlement to resolve lawsuits claiming its Roundup weedkiller caused non-Hodgkin lymphoma, a type of cancer. The settlement, if approved by the court, would involve annual payments over 21 years and allow affected people exposed before the announcement to file claims.Key Facts
- Bayer’s Monsanto subsidiary proposed a $7.25 billion settlement for Roundup cancer lawsuits.
- The lawsuits claim Roundup caused non-Hodgkin lymphoma, a cancer of the immune system’s white blood cells.
- Payments would be made over 21 years if the settlement is approved by a court.
- People diagnosed with non-Hodgkin lymphoma exposed to Roundup before the announcement can file claims.
- Bayer says the settlement does not mean it admits fault or wrongdoing.
- Bayer’s total estimated legal costs for these cases would rise from €7.8 billion to €11.8 billion ($9.2 billion to $13.9 billion).
- Bayer bought Monsanto in 2018 and is facing thousands of lawsuits related to Roundup.
- Roundup remains available for sale, and Bayer says its products are safe and well tested.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
